PROTOCOL: CA209-76K (PI: DR VICTORIA ATKINSON)

Short Title: CheckMate 76K

Protocol Title: A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy With Nivolumab Versus Placebo After Complete Resection of Stage IIB/C Melanoma

Lay Title: Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma

Click here for more information

 

PROTOCOL: CA224-047 (PI: DR VICTORIA ATKINSON) (PART E ONLY)

Protocol Title: A Randomized, Double-Blind Phase 2/3 Study of Relatlimab Combined With Nivolumab Versus Nivolumab in Participants With Previously Untreated Metastatic or Unresectable Melanoma

Lay Title: A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Click here for more information

 

PROTOCOL: CA209-7CK (PI: DR VICTORIA ATKINSON)

Protocol Title: A prospective, observational study in patients receiving adjuvant nivolumab therapy for resected melanoma in Australia

Lay Title: An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia

Click here for more information

 

RETURN TO CLINICAL TRIALS PAGE